BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Monday, May 13, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 15, 2000
View Archived Issues
La Jolla's lupus drug effective in patients with high-affinity antibodies
Read More
Cortex achieves first milestone in Organon agreement
Read More
Generex initiates long-term phase II trials of oral insulin formulation
Read More
Acadia and ArQule enter licensing agreement for lead serotonergic compounds
Read More
Vion expands TAPET trials, advances other products
Read More
SIB-1893 and other mGluR5 antagonists claimed for pain and anxiety
Read More
Fujisawa's new oxazole compounds particularly useful for glomerulonephritis
Read More
Chloride channel blockers as novel therapeutic approach to sickle cell disease and other disorders
Read More
Naphthalenecarboxamide-based tachykinin antagonists in development by AstraZeneca
Read More
Tanabe Seiyaku patents new inhibitors of PDE5
Read More
New lactones with anti-MRSA activity designed at Sankyo
Read More
Several new patents issued to Janssen for alpha2-adrenoceptor antagonists and their use
Read More
Memantine should be advanced to late-stage trials in PPN according to phase II results
Read More
Sepracor updates product development
Read More
TP-10 phase I/II study results presented at cardiovascular anesthesiology meeting
Read More
Nexell forms cell therapy and gene therapy alliance with Takara Shuzo
Read More
Ligand releases new data confirming Ontak's effectiveness in patients with severe psoriasis
Read More
Pregabalin phase I, phase II trials in painful peripheral neuropathy reported at AAN meeting
Read More
Therion's Prostvac vaccine shows promise in phase I prostate cancer study
Read More
United Therapeutics to begin Flolan-to-Uniprost transition study
Read More
AU-461 headed for development as a novel therapeutic agent for peptic ulcer
Read More
Medarex highlights Q1 developments marked by continued partnership arrangements
Read More
Pharmacological profile of SL-650472, a novel antiplatelet, antithrombotic agent
Read More
Elan completes acquisition of The Liposome Company
Read More
HCT-1026 enters phase II trials for overactive bladder
Read More
CNS-5161 being rapidly advanced to phase II for pain; development partner will be sought
Read More